2 weeks Ago By Defense World Staff
Alliancebernstein L.P. lessened its stake in shares of Core Laboratories Inc.
( NYSE:CLB – Free Report ) by 10.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 49,613 shares of the oil and gas company’s stock after selling 5,987 shares during the quarter.
Alliancebernstein L.P. owned approximately 0.
11% of Core Laboratories worth $859,000 at the end of the most recent reporting period. A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Assetmark Inc.
purchased a new stake in shares of Core Laboratories during the 4th quarter worth $26,000. Smartleaf Asset Management LLC lifted its position in shares of Core Laboratories by 173.8% during the fourth quarter.
Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock valued at $35,000 after buying an additional 1,293 shares during the last quarter. Nisa Investment Advisors LLC boosted its holdings in shares of Core Laboratories by 2,688.5% in the 4th quarter.
Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock valued at $42,000 after buying an additional 2,339 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of Core Laboratories in the 4th quarter worth approximately $149,000. Finally, Isthmus Partners LLC grew its position in shares of Core Laboratories by 5.
6% in the 4th quarter. Isthmus Partners LLC now owns 11,219 shares of the oil and gas company’s stock worth $194,000 after buying an additional 599 shares during the last quarter. 97.
81% of the stock is currently owned by hedge funds and other institutional investors. Analyst Upgrades and Downgrades CLB has been the subject of several recent analyst reports. Citigroup upgraded shares of Core Laboratories from a “sell” rating to a “neutral” rating and raised their target price for the company from $15.
00 to $16.00 in a research note on Wednesday, March 12th. Stifel Nicolaus lowered their price objective on Core Laboratories from $19.
00 to $15.00 and set a “hold” rating for the company in a research report on Tuesday, April 15th. One investment analyst has rated the stock with a sell rating and four have issued a hold rating to the company.
According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $15.75. Core Laboratories Stock Up 2.
1 % NYSE:CLB opened at $12.58 on Friday. The company has a current ratio of 2.
32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49.
Core Laboratories Inc. has a twelve month low of $10.14 and a twelve month high of $25.
13. The company has a market cap of $587.28 million, a PE ratio of 19.
05, a P/E/G ratio of 0.99 and a beta of 1.99.
The company’s 50 day moving average is $14.53 and its two-hundred day moving average is $17.44.
Core Laboratories ( NYSE:CLB – Get Free Report ) last announced its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.
23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.
24%. Analysts anticipate that Core Laboratories Inc. will post 0.
96 EPS for the current year. Core Laboratories Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Monday, February 10th were paid a $0.
01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.
32%. The ex-dividend date of this dividend was Monday, February 10th. Core Laboratories’s payout ratio is 6.
06%. Core Laboratories Profile ( Free Report ) Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments.
The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. Further Reading Five stocks we like better than Core Laboratories CD Calculator: Certificate of Deposit Calculator J.B.
Hunt Transport Overcorrects Into a Buying Opportunity How Investors Can Find the Best Cheap Dividend Stocks AppLovin: Can Record Profits Overcome Market Skepticism? High Flyers: 3 Natural Gas Stocks for March 2022 MarketBeat Week in Review – 04/14 – 04/18 Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter ..
